Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filtrum-STI in children with viral gastroenteritis
NCT01113346Phase 3Unknown
- Sponsor
- AVVA RUS JSC
- Start
- Jun 2010
- Primary completion
- Dec 2010
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lignin hydrolytic in viral gastroenteritis, sponsored by AVVA RUS JSC. Primary endpoint: Severity of gastroenteritis at 7 days. Status: unknown.
02
Drugs
lignin hydrolytic
03
Conditions
viral gastroenteritis
Beyond the preview
Go deeper on NCT01113346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01113346.